Dashboard
Analysis
Charting
Screener
Resources
Settings
NYSE-FICO
Sep '05
Sep '08
Sep '11
Sep '14
Sep '17
Sep '20
Sep '23
LTM
Trailing Valuation
Stock Price
1,845
1,943.5
868.5
412
397.9
425.4
303.5
228.6
140.5
124.6
Total Shares Outstanding
23.7
24.4
—
Market Cap
43,742.7
47,406.3
Total Enterprise Value (TEV)
46,628.8
49,441.4
Dividend Yield
0%
0.1%
Buyback Yield
3.6%
2%
Debt Paydown Yield
-2%
-0.7%
Shareholder Yield
1.7%
1.2%
P/S
22
27.6
P/Gross Profit
26.7
34.6
P/E
69.5
95
51.3
29.1
29.7
53.8
47.9
56.3
33.9
36.8
Earnings Yield
1.4%
1.1%
1.9%
3.4%
2.1%
1.8%
2.9%
2.7%
P/OCF
56.2
74.9
P/FCF
56.8
76
FCF Yield
1.3%
P/B
-25.1
-49.2
EV/Sales
23.4
28.8
EV/Gross Profit
28.5
36.1
EV/EBITDA
49.6
66.1
EV/EBIT
50.4
67.4
EV/OCF
59.9
78.1
EV/FCF
60.6
79.2
Dividends
DPS
0
0.1
Payout Ratio
1%
2.3%
Margins
Gross Profit Margin
82.2%
79.7%
79.4%
78.1%
74.7%
72.1%
71%
68.7%
69.2%
69.9%
Operating Margin
46.5%
42.7%
42.5%
39.4%
38.4%
22.9%
21.9%
17.5%
19%
19.2%
EBITDA Margin
47.2%
43.5%
43.4%
40.9%
40.3%
25.2%
24.6%
20.6%
22.8%
Net Profit Margin
32.7%
29.9%
28.4%
27.1%
29.8%
18.3%
16.6%
12.6%
13.8%
12.4%
Effective Tax Rate
18.8%
20.1%
22.4%
20.7%
17.1%
8%
11.1%
19.4%
15.2%
24.3%
Pre-Tax Profit Margin
37.4%
36.6%
34.2%
35.9%
19.9%
18.6%
15.7%
16.2%
16.4%
Free Cash Flow Margin
38.7%
36.3%
30.7%
31.6%
26.5%
20.4%
22.1%
21.4%
OCF / Sales
39.1%
36.9%
31%
37%
32.2%
28.2%
22.3%
24.2%
23.9%
OCF / Net Income
119.5%
123.4%
109.2%
136.4%
108.1%
154.4%
135.5%
176.4%
175.9%
192.1%
FCF / OCF
98.9%
98.6%
99.1%
98.8%
98.2%
94%
90.8%
86%
91.2%
89.6%
FCF / Net Income
118.1%
121.7%
108.2%
134.8%
106.2%
145.1%
123%
151.6%
160.5%
172%
FCF / EBITDA
81.9%
83.5%
70.7%
89.4%
78.4%
105.1%
82.9%
93.3%
96.4%
93.6%
Capital Efficiency
Return on Invested Capital
42.9%
46.2%
42.8%
34.7%
21%
11.7%
13.5%
11.9%
Return on Assets
42%
35.6%
33%
28.6%
26.4%
17.9%
16.3%
10.9%
12.1%
10.5%
Return on Equity
-45.2%
-62.1%
-57.6%
-81.8%
356.2%
76.2%
66.6%
35.4%
29.4%
24.8%
Return on Total Capital
24.4%
28.5%
26.8%
37.7%
31.4%
25.5%
21.8%
Return on Capital Employed
57.6%
55.5%
51.2%
45.9%
27.7%
19.6%
17.3%
Return on Tangible Assets
60.1%
59.1%
58%
51.4%
50.3%
33.8%
34%
31.3%
28.9%
Receivables Turnover
4.5
4.2
4.3
4.1
4.6
5.5
5.4
Days Sales Outstanding
80.7
86.6
85.7
84.1
89.6
89
88.8
79.4
65.9
67.6
Payables Turnover
12.7
16.8
17.1
15.9
15.2
15.7
15.5
13.5
12.4
Days Payables Outstanding
28.6
21.7
21.3
23
24
23.3
23.5
23.2
27
29.5
Cash Conversion Cycle
52
64.8
64.4
61.1
65.6
65.7
65.3
38.9
38.2
Asset Turnover
1.1
1
0.9
0.8
0.7
Fixed Asset Turnover
24.1
32.8
33.3
14.7
16.5
22.8
22.3
21.2
Operating Cycle
CapEx to OCF
CapEx to Revenue
CapEx to Depreciation
0.6
0.3
0.5
Financial Health
Total Debt
3,074.9
2,231
1,885.6
1,892.9
1,312.7
907.6
824.8
763.9
604.8
570.6
Net Debt
2,886.1
2,035
1,715.8
1,735.1
1,085.5
724.7
698.1
655.9
485.4
483.7
Current Ratio
1.6
1.5
1.3
Quick Ratio
1.4
1.2
Cash Ratio
0.2
0.4
Debt Ratio
Assets to Equity
-1.1
-1.8
-2.3
-14.1
4.9
2.9
2.7
Cash Flow to Debt Ratio
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-2,908.8
-2,063.2
-1,706.8
-1,759.3
-1,127.7
-741.1
-688
-646.6
-518.2
-506.2
Goodwill / Assets
Debt / Equity
-2.7
-2.4
-11.8
2.8
Total Debt / Capitalization
Long Term Debt / Capitalization
Long-Term Debt / Equity
-1.5
-9.6
2.5
2.1
1.8
Net Debt / EBITDA
3.1
2.6
2
2.2
2.4
3.2
2.3
EBIT / Interest Expense
6.9
6.7
7.9
12.6
7
6.4
5.6
EBITDA / Interest Expense
7.1
8.2
13.2
7.7
7.2
6.6
8.3
7.6
(EBITDA - Capex) / Interest Expense
6.8
8.1
13.1
7.5
Per Share
Revenue per Share
81.1
68.5
59.7
52.3
45
43.3
38.3
32.1
28.9
27.3
Basic EPS
26.9
20.8
17.2
14.3
13.7
3.5
Diluted EPS
26.5
20.5
16.9
14.2
13.4
6.3
3.4
Book Value per Share
-71.1
-38.4
-27.1
-30.4
-3.8
11.1
9.6
9.2
13.8
Tangible Book Value per Share
-103
-69.6
-57.6
-59.4
-30.9
-16.4
-17.4
-16.9
-12.4
-11.9
Cash per Share
7.8
6
6.1
3.7
Operating Cash Flow per Share
31.7
25.2
18.5
19.3
14.5
12.2
8.6
6.5
Free Cash Flow per Share
31.3
24.9
18.3
19.1
11.5
5.8
CapEx per Share
Weighted Avg. Shares Outstanding
24.2
24.7
25
26
28.7
29
30.9
31.1
Weighted Avg. Shares Outstanding Diluted
24.6
25.1
25.4
26.3
29.3
29.9
30.3
31.2
32.2
32.3
Common Size
R&D to Revenue
9.5%
10%
10.6%
10.7%
13%
12.9%
12.8%
11.8%
SG&A to Revenue
25.8%
26.9%
27.9%
30.1%
32.5%
35.7%
36.5%
37.3%
Stock-based Comp to Revenue
7.9%
8.7%
8.2%
8.4%
8.5%
7.2%
7.5%
6.6%
6.3%
